Peptides
Semax
- Research classification
- Peptides
For laboratory research use only. Not for human or veterinary use.
Lot & quality
Lot-specific analytical documentation
No verified lot documentation is published for this compound yet. Results, laboratories and purity values are never shown without a source record for the exact lot.
View available lot-specific analytical documentationEnter lot number
Verification connects to the BioNex lot and COA records in a later phase — no results are returned yet
- 01
Lot Number
- 02
COA
- 03
HPLC
- 04
Mass Spectrometry
- 05
Purity
- 06
Laboratory
- 07
Testing Date
- 08
QR Verification
Research snapshot
Verified research records currently indexed by BioNex
- Publication records
- 81
- Human interventional
- 2
- Human observational
- 3
- Preclinical
- 9
- Reviews
- 1
- International records
- 31
- Years indexed
- 2002–2026
Categories are listed separately and must not be added together: publication records and registered trial records are different record types, and a single study may appear in more than one category.
Compound profile
Research overview
Curated research content has not yet been imported for this compound. No generated summary is shown in its place.
Classification
Research areas
- Neuropeptide Research
Targets
Mechanisms under investigation
Modulation of immune-response and vascular gene expression in experimental cerebral ischaemia
Gene-expression modulation (preclinical)
Rat cerebral ischaemia–reperfusion studies report altered expression of immune-response and vascular genes following administration of the ACTH(4-7)PGP peptide. Mechanism is under investigation in animal models only; relevance to any human context is not established.
Source
Evidence
Evidence breakdown
Direct compound evidence
81
Publication records indexed as describing this compound directly.
Related evidence
0
Parent-molecule or fragment literature. Counted separately and never added to direct evidence.
Human research
- Human interventional2
- Human observational3
Records describing research in human participants.
Preclinical research
- Animal9
Animal and laboratory records. Not human evidence.
Review literature
- Reviews1
Reviews summarise other work rather than reporting new results.
Scientific identity
Compound identity
- Canonical scientific name
- Semax (ACTH(4-7) analogue Met-Glu-His-Phe-Pro-Gly-Pro; ACTH(4-10)-derived heptapeptide)
- Sequence
- MEHFPGP
- Sequence length
- 7 residues
- Research classification
- Peptides
These records describe the scientific entity reported in the literature. Lot-specific analytical documentation is available through BioNex Quality Verification when provided for the applicable lot.
Scientific data
- Compound
- Semax
- Peptide sequence
- MEHFPGP
- Research classification
- Peptides
Global research
Research records by jurisdiction
Jurisdictions appear only where an indexed record establishes them. Research recorded in one country never implies authorisation in another.
Loading Russia records
Published research
Representative recent records
Verified records currently indexed by BioNex
Loading records
Regulatory
Regulatory records by jurisdiction
Regulatory records are held separately from research evidence. Authorisation or regulatory activity in one jurisdiction never implies the same status in another.
Russian Federation: Pharmaceutical substance register record ЛС-002373 dated 15.12.2006; an official Ministry of Health notice of exclusion of this pharmaceutical-substance record from the state register was published 20.01.2026.
Ministry of Health of the Russian Federation — State Register of Medicines (GRLS) · Семакс® (pharmaceutical substance)
Primary source
Scientific identity records describe the entity reported in the literature. Lot-specific analytical documentation is available through BioNex Quality Verification when provided for the applicable lot.
BioNex Research Intelligence summarizes and organizes scientific literature for research and educational purposes. Inclusion of a publication, clinical trial, or regulatory record does not constitute endorsement, clinical guidance, or evidence of safety or efficacy for human use.
Related
